Structural basis for recognition of two HLA-A2-restricted SARS-CoV-2 spike epitopes by public and private T cell receptors

T cells play a vital role in combatting SARS-CoV-2 and in forming long-term memory responses. Whereas extensive structural information is available on neutralizing antibodies against SARS-CoV-2, such information on SARS-CoV-2-specific T cell receptors (TCRs) bound to their peptide–MHC targets is lacking. We determined structures of a public and a private TCR from COVID-19 convalescent patients in complex with HLA-A2 and two SARS-CoV-2 spike protein epitopes (YLQ and RLQ). The structures revealed the basis for selection of particular TRAV and TRBV germline genes by the public but not the private TCR, and for the ability of both TCRs to recognize natural variants of YLQ and RLQ but not homologous epitopes from human seasonal coronaviruses. By elucidating the mechanism for TCR recognition of an immunodominant yet variable epitope (YLQ) and a conserved but less commonly targeted epitope (RLQ), this study can inform prospective efforts to design vaccines to elicit pan-coronavirus immunity.

[1]  A. Tonevitsky,et al.  T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations , 2021, bioRxiv.

[2]  R. Scheuermann,et al.  Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals , 2021, Cell Reports Medicine.

[3]  H. Schuitemaker,et al.  Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans , 2021, Nature.

[4]  P. Dormitzer,et al.  BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans , 2021, Nature.

[5]  Bjoern Peters,et al.  SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19 , 2021, Cell Host & Microbe.

[6]  B. Haynes,et al.  A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice , 2021, bioRxiv.

[7]  S. Kent,et al.  CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity , 2021, Immunity.

[8]  C. Szeto,et al.  CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses , 2021, Immunity.

[9]  D. Burton,et al.  A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection , 2021, bioRxiv.

[10]  P. Dormitzer,et al.  Neutralizing Activity of BNT162b2-Elicited Serum , 2021, The New England journal of medicine.

[11]  R. Valenta,et al.  SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses , 2021, Science Immunology.

[12]  D. Ho,et al.  Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 , 2021, bioRxiv.

[13]  S. Mallal,et al.  Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2021, Cell Reports Medicine.

[14]  A. Casadevall,et al.  SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. , 2021, The Journal of clinical investigation.

[15]  Bjoern Peters,et al.  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.

[16]  T. Mora,et al.  Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection , 2021, eLife.

[17]  S. Mallal,et al.  Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2020, bioRxiv.

[18]  J. Mascola,et al.  Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination , 2020, The New England journal of medicine.

[19]  S. Ladhani,et al.  Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection , 2020, bioRxiv.

[20]  M. Nussenzweig,et al.  SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies , 2020, Nature.

[21]  H. Rammensee,et al.  SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition , 2020, Nature immunology.

[22]  I. Wilson,et al.  An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain , 2020, Cell Reports.

[23]  Jared Adolf-Bryfogle,et al.  CoV3D: a database of high resolution coronavirus protein structures , 2020, Nucleic Acids Res..

[24]  P. Sopp,et al.  Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 , 2020, Nature Immunology.

[25]  Matthew S. Miller,et al.  Immunological considerations for COVID-19 vaccine strategies , 2020, Nature Reviews Immunology.

[26]  S. Farhadian,et al.  Sex differences in immune responses that underlie COVID-19 disease outcomes , 2020, Nature.

[27]  J. McCluskey,et al.  Atypical TRAV1-2− T cell receptor recognition of the antigen-presenting molecule MR1 , 2020, The Journal of Biological Chemistry.

[28]  S. Mallal,et al.  Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans , 2020, Science.

[29]  U. Reimer,et al.  SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 , 2020, Nature.

[30]  D. Altmann,et al.  SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection , 2020, Science Immunology.

[31]  Martin Linster,et al.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.

[32]  S. Perlman,et al.  Lessons for COVID-19 Immunity from Other Coronavirus Infections , 2020, Immunity.

[33]  D. Burton,et al.  Structural basis of a shared antibody response to SARS-CoV-2 , 2020, Science.

[34]  A. Sette,et al.  Pre-existing immunity to SARS-CoV-2: the knowns and unknowns , 2020, Nature Reviews Immunology.

[35]  Morten Nielsen,et al.  Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 , 2020, Cell.

[36]  Qiang Zhou,et al.  A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2 , 2020, Science.

[37]  C. Rice,et al.  Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals , 2020, Nature.

[38]  B. Pierce,et al.  Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen , 2020, Nature Communications.

[39]  G. A. Efimov,et al.  SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors , 2020, Immunity.

[40]  J. Greenbaum,et al.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.

[41]  W. Wang,et al.  Viral and host factors related to the clinical outcome of COVID-19 , 2020, Nature.

[42]  Amalio Telenti,et al.  Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody , 2020, Nature.

[43]  Meriem Bensouda Koraichi,et al.  Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection , 2020, bioRxiv.

[44]  Morten Nielsen,et al.  NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data , 2020, Nucleic Acids Res..

[45]  M. Chiarini,et al.  Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover , 2020, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[46]  B. Cowie,et al.  Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 , 2020, Nature Medicine.

[47]  M. Letko,et al.  Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.

[48]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[49]  L. Gostin,et al.  The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. , 2020, JAMA.

[50]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[51]  Jia-huai Wang,et al.  Structural basis of assembly of the human T cell receptor–CD3 complex , 2019, Nature.

[52]  Xin Li,et al.  Global Epidemiology of Bat Coronaviruses , 2019, Viruses.

[53]  R. Hagedoorn,et al.  A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies , 2018, Oncotarget.

[54]  G. Alexe,et al.  Origin and differentiation of human memory CD8 T cells after vaccination , 2017, Nature.

[55]  Stefan Elbe,et al.  Data, disease and diplomacy: GISAID's innovative contribution to global health , 2017, Global challenges.

[56]  A. Bertoletti,et al.  Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection , 2016, Vaccine.

[57]  K. Lindkvist-Petersson,et al.  Structure of Staphylococcal Enterotoxin E in Complex with TCR Defines the Role of TCR Loop Positioning in Superantigen Recognition , 2015, PloS one.

[58]  Zhiping Weng,et al.  Backbone flexibility of CDR3 and immune recognition of antigens. , 2014, Journal of molecular biology.

[59]  Zhiping Weng,et al.  Computational Design of the Affinity and Specificity of a Therapeutic T Cell Receptor , 2014, PLoS Comput. Biol..

[60]  K. Katoh,et al.  MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.

[61]  Z. Weng,et al.  A flexible docking approach for prediction of T cell receptor–peptide–MHC complexes , 2013, Protein science : a publication of the Protein Society.

[62]  R. Mariuzza,et al.  Structural basis for self‐recognition by autoimmune T‐cell receptors , 2012, Immunological reviews.

[63]  P. Zwart,et al.  Towards automated crystallographic structure refinement with phenix.refine , 2012, Acta crystallographica. Section D, Biological crystallography.

[64]  Jiahuai Han,et al.  Determinants of public T cell responses , 2012, Cell Research.

[65]  K. Garcia,et al.  T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. , 2011, Immunity.

[66]  Hong Yang,et al.  Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study , 2011, The Journal of Immunology.

[67]  Andrew K. Sewell,et al.  Genetic and Structural Basis for Selection of a Ubiquitous T Cell Receptor Deployed in Epstein-Barr Virus Infection , 2010, PLoS pathogens.

[68]  L. Fugger,et al.  An Alternative Conformation of the T-Cell Receptor α Constant Region , 2010, Journal of molecular biology.

[69]  Jincun Zhao,et al.  T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice , 2010, Journal of Virology.

[70]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[71]  J. McCluskey,et al.  The shaping of T cell receptor recognition by self-tolerance. , 2009, Immunity.

[72]  A. McMichael,et al.  T Cell Responses to Whole SARS Coronavirus in Humans1 , 2008, The Journal of Immunology.

[73]  Ralph Baric,et al.  A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice , 2007, PLoS pathogens.

[74]  Daniel C. Douek,et al.  Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination , 2006, Proceedings of the National Academy of Sciences.

[75]  Wladek Minor,et al.  HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes. , 2006, Acta crystallographica. Section D, Biological crystallography.

[76]  Robyn L Stanfield,et al.  How TCRs bind MHCs, peptides, and coreceptors. , 2006, Annual review of immunology.

[77]  Zbyszek Otwinowski,et al.  The integration of data reduction and structure solution - from diffraction images to an initial model in minutes , 2005 .

[78]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Rotation Functions Biological Crystallography Likelihood-enhanced Fast Rotation Functions , 2003 .

[79]  David E. Kim,et al.  Computational Alanine Scanning of Protein-Protein Interfaces , 2004, Science's STKE.

[80]  Willie R. Watson,et al.  A computational and experimental study of slit resonators , 2003 .

[81]  J. Drijfhout,et al.  Detailed motifs for peptide binding to HLA-A*0201 derived from large random sets of peptides using a cellular binding assay. , 1995, Human immunology.

[82]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[83]  M. Ravid,et al.  A Six-Year Follow-up Study , 2016 .

[84]  K. Katoh,et al.  Improvements in Performance and Usability , 2013 .

[85]  G. Davies,et al.  Knowns and Unknowns , 2003 .